Schedule 13G ownership disclosure
Melinta Therapeutics Inc
Security class unavailable · CUSIP: 58549G100
Event date: 2019-01-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.7600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-19-000060
- Form type
- SC 13G
- Filer
- Flynn James E
- CIK
- CIK 1352546
- Filed
- Jan 16, 2019
- Reporting period
- Jan 14, 2019
- Description
- Schedule 13G beneficial ownership